Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07016074 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury

StatusRecruiting
PhasePhase 2
Started2025-06-30
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Jul 2026 → Oct 2026
See other at-risk trials from University of Michigan

Amendment history

2026-07-24
Study Status v3
Primary completion pushed: 2026-07 → 2026-10
Completion pushed: 2026-07 → 2026-11
2026-02-22
Study Status, Oversight, Study Description, Outcome Measures v2
Primary endpoints6 entries, revised
Percent of participants with 48-hour basic metabolic panel collected between 36-60108 hours of contrast exposure
Study description+529 characters
The timing of the follow-up blood test was changed from 48 hours (± 12 hours) to 72 hours (± 36 hours) after contrast exposure. This change allows participants more flexibility to complete their lab work at a convenient outpatient location without requiring a return visit within a narrow time window [...]
2025-07-15
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-06→confirmed 2025-06-30
Study sitesdetails revised at 1 of 1 site
2025-06-03
Original filing
This pilot study is designed to test the logistics and recruitment of a trial testing the benefit of sodium nitrate in the prevention of contrast-associated kidney injury in a group of patients at high-risk.
Trial Details
NCT Number NCT07016074
Lead Sponsor University of Michigan
Conditions Kidney Injury, Acute
Enrollment 100 participants
Start Date 2025-06-30
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-27